Janghee Woo
- Department of Hematology and Medical Oncology
Assistant Professor
- (404) 778-8370
- janghee.woo@emory.edu
- Woo Lab
Overview
Board certified in internal medicine and medical oncology, Dr. Woo specializes in the treatment of hematologic malignancies with stem cell transplant and cellular therapy.
Dr. Woo received his Medical Degree from Seoul National University in South Korea. He earned his PhD in Genetics from Harvard University in Cambridge, Massachusetts. After completing PhD training, he completed a residency in Internal Medicine at Albert Einstein Medical Center in Philadelphia, Pennsylvania, followed by a fellowship in Hematology/Oncology at Fred Hutchinson Cancer Center/University of Washington in Seattle, Washington.
Dr. Woo's research focuses on understanding molecular mechanisms of hematologic disorders with a particular interest in the biological and molecular consequences of clonal hematopoiesis and developing new therapeutic modalities in hematological malignancy.
Dr. Woo's research has garnered notable recognition, such as the Paul Calabresi Career Developmental Award from the National Cancer Institute, Celgene Awards for Clinical Research in Hematology and Evans MDS Young Investigator Award for his innovative research and significant contributions to the field. Before joining Emory University, Dr. Woo held a pivotal role directing translational and early clinical research programs in hematology at the Novartis Institutes for BioMedical Research (NIBR). This unique experience expanded his expertise in the development of novel therapeutic strategies, emphasizing his commitment to translating research findings into practical solutions.
Academic Appointment
- Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
Education
Degrees
- MD from Seoul National University
- PhD from Harvard Medical School
Research
Publications
-
Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial.
Cancer Prev Res (Phila) Volume: 17 Page(s): 429 - 436
09/04/2024 Authors: Woo J; Zhai T; Yang F; Xu H; Healey ML; Yates DP; Beste MT; Steensma DP -
Effects of IL-1 inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial.
Blood Adv Volume: 7 Page(s): 7471 - 7484
12/26/2023 Authors: Woo J; Lu D; Lewandowski A; Xu H; Serrano P; Healey M; Yates DP; Beste MT; Libby P; Ridker PM -
Activation of distinct inflammatory pathways in subgroups of LR-MDS.
Leukemia Volume: 37 Page(s): 1709 - 1718
08/01/2023 Authors: Schneider M; Rolfs C; Trumpp M; Winter S; Fischer L; Richter M; Menger V; Nenoff K; Grieb N; Metzeler KH -
Interleukin-1 (IL-1) and the inflammasome in cancer.
Cytokine Volume: 153 Page(s): 155850
05/01/2022 Authors: Pretre V; Papadopoulos D; Regard J; Pelletier M; Woo J -
BAFF receptor antibody for mantle cell lymphoma therapy.
Oncoimmunology Volume: 10 Page(s): 1893501
03/05/2021 Authors: Zhang K; Roy NK; Vicioso Y; Woo J; Beck R; de Lima M; Caimi P; Feinberg D; Parameswaran R -
Hedgehog-Activated Fat4 and PCP Pathways Mediate Mesenchymal Cell Clustering and Villus Formation in Gut Development.
Dev Cell Volume: 52 Page(s): 647 - 658.e6
03/09/2020 Authors: Rao-Bhatia A; Zhu M; Yin W-C; Coquenlorge S; Zhang X; Woo J; Sun Y; Dean CH; Liu A; Hui C-C -
Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia.
Haematologica Volume: 105 Page(s): 652 - 660
03/01/2020 Authors: Woo J; Choi DR; Storer BE; Yeung C; Halpern AB; Salit RB; Sorror ML; Woolston DW; Monahan T; Scott BL -
Asymmetric dimethylarginine - a prognostic marker for transplant outcome?
Haematologica Volume: 104 Page(s): 646 - 647
04/01/2019 Authors: Woo J; Deeg HJ -
Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes.
Biol Blood Marrow Transplant Volume: 24 Page(s): 386 - 392
02/01/2018 Authors: Samuelson Bannow BT; Salit RB; Storer BE; Stevens EA; Wu D; Yeung C; Fang M; Petersdorf EW; Linenberger ML; Woo J -
Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes.
Haematologica Volume: 102 Page(s): e216 - e218
06/01/2017 Authors: Woo J; Howard NP; Storer BE; Fang M; Yeung CC; Scott BL; Deeg HJ